Treg-based therapy and mixed chimerism in small intestinal transplantation: Does Treg+BMT equal intestine allograft tolerance?

Medical Hypotheses

Volumn 76, Issue 1, 2011, Pages 77-78

  Du, Jun Feng ^a   Li, Shi Yong ^a   Yu, Bo ^a   Bai, Xue ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN;

ADOPTIVE TRANSFER; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; INTESTINE TRANSPLANTATION; ISCHEMIA; REGULATORY T LYMPHOCYTE; REPERFUSION INJURY; SMALL INTESTINE TRANSPLANTATION; ALLOTRANSPLANTATION; ANIMAL; IMMUNOLOGY; MOUSE; SMALL INTESTINE; TRANSPLANTATION;

RODENTIA;

ANIMALS; GRAFT REJECTION; IMMUNE TOLERANCE; INTESTINE, SMALL; MICE; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 78650169965     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.08.035     Document Type: Article

References (20)

1. Ruiz P., Kato T., Tzakis A. Current status of transplantation of the small intestine. Transplantation 2007, 83(1):1-6.
2. Kawai T., Cosimi A.B., Spitzer T.R., et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008, 358(4):353-361.
3. Joffre O., Santolaria T., Calise D., et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 2008, 14(1):88-92.
4. Graca L., Daley S., Fairchild P.J., Cobbold S.P., Waldmann H. Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning. BMC Immunol 2006, 7:9.
5. Wekerle T., Kurtz J., Ito H., et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 2000, 6(4):464-469.
6. Guo Z., Wang J., Dong Y., et al. Long-term survival of intestinal allografts induced by costimulation blockade, busulfan and donor bone marrow infusion. Am J Transplant 2003, 3(9):1091-1098.
7. Bigenzahn S., Blaha P., Koporc Z., et al. The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade. Am J Transplant 2005, 5(6):1237-1247.
8. Pilat N, Baranyi U, Klaus C, et al. Treg-Therapy Allows Mixed Chimerism and Transplantation Tolerance Without Cytoreductive Conditioning. Am J Transplant 2010 Feb 10. [Epub ahead of print].
9. He K.M., Ma Y., Wang S., et al. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance. Eur J Immunol 2007, 37(12):3455-3466.
10. Kurtz J., Wekerle T., Sykes M. Tolerance in mixed chimerism - a role for regulatory cells?. Trends Immunol 2004, 25(10):518-523.
11. Walsh P.T., Taylor D.K., Turka L.A. Tregs and transplantation tolerance. J Clin Invest 2004, 114(10):1398-1403.
12. Golshayan D., Jiang S., Tsang J., et al. In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood 2007, 109(2):827-835.
13. Dai Z., Li Q., Wang Y., et al. CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. J Clin Invest 2004, 113(2):310-317.
14. Barao I., Hanash A.M., Hallett W., et al. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. Proc Natl Acad Sci USA 2006, 103(14):5460-5465.
15. Jaeckel E., von Boehmer H., Manns M.P. Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 2005, 54(2):306-310.
16. Sayegh M.H., Weiner H.L. Regulating rejection with cell therapy. Nat Biotechnol 2008, 26(2):191-192.
17. Edinger M., Hoffmann P., Ermann J., et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003, 9(9):1144-1150.
18. Cohen J.L., Trenado A., Vasey D., Klatzmann D., Salomon B.L. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 2002, 196(3):401-406.
19. Perico N., Cattaneo D., Sayegh M.H., Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004, 364(9447):1814-1827.
20. Kinsey G.R., Sharma R., Huang L., et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 2009, 20(8):1744-1753.